GlassScriptPhysician profile
Sudeep D Burman
NPI 1114277639
$71,685.40
in general payments reported to CMS, 2019-2025
27 companies · $7,090 in 2025
The $7,090 reported for 2025 was more than what 93% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,827 · 2020: $14K · 2021: $5,262 · 2022: $3,032 · 2023: $14K · 2024: $21K · 2025: $7,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $14K · Travel and Lodging: $12K · Food and Beverage: $9,680 · Consulting Fee: $6,000 · Honoraria: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $13,500.00 |
| Travel and Lodging | $12,315.21 |
| Food and Beverage | $9,680.08 |
| Consulting Fee | $6,000.00 |
| Honoraria | $520.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $37,630.88 | 2019-2025 | Da Vinci Surgical System |
| Conmed Corporation | $7,788.43 | 2023-2025 | Airseal |
| Davol INC. | $6,592.39 | 2021-2025 | Phasix Mesh, Arista Ah Flexitip, Arista |
| Tela Bio, INC. | $6,042.11 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| W. L. Gore & Associates, INC. | $5,448.74 | 2019-2024 | Gore Bio-A Tissue Reinforcement, Gore Enform Preperitoneal Biomaterial, Seamguard Staple Line Reinforcement |
| Stryker Corporation | $2,090.69 | 2021-2024 | 1788, Spy-Phi System |
| Acera Surgical, INC. | $1,895.58 | 2024-2025 | Restrata Wound Matrix |
| Distalmotion US | $1,387.90 | 2024 | Dexter L6 Robot |
| Becton, Dickinson and Company | $1,039.87 | 2023-2024 | Phasix Mesh, Arista Ah Flexitip |
| Medtronic, INC. | $304.71 | 2021-2024 | Progrip, Intellis Adaptivestim |
| Integra Lifesciences Corporation | $231.91 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Inspire Medical Systems, INC. | $215.52 | 2024 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $156.51 | 2020-2023 | Gattex |
| Abbott Laboratories | $140.72 | 2022 | |
| Medical Device Business Services, INC. | $139.37 | 2025 | Vistaseal |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $87.81 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Acell, INC. | $83.96 | 2019 | |
| Endogastric Solutions, INC | $82.09 | 2023 | Esophyx |
| Covidien LP | $75.51 | 2019 | |
| Medacta USA, INC. | $50.00 | 2022 | |
| Access Pro Medical, LLC | $45.03 | 2023 | Matriderm |
| Mimedx Group, INC. | $37.57 | 2024 | |
| Axogen | $36.02 | 2025 | |
| Srs Medical Systems, INC. | $24.04 | 2024 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Ethicon US, LLC | $20.60 | 2025 | Surgicel Nu-Knit, Vistaseal |
| Teleflex LLC | $19.04 | 2020 | |
| Dilon Technologies, INC. | $18.40 | 2024 | Hemoblast Bellows |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sudeep Burman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.